ClinicalTrialsFinder

Relapsing or Refractory Multiple Sclerosis (MS) Clinical Trials in Wuhan, Hubei

1 recruitingWuhan, Hubei, China

Showing 1–1 of 1 trials

Recruiting
Early Phase 1

CD19/BCMA-Targeted UCAR-T for Patients With Neurological Autoimmune Diseases

Relapsing or Refractory Multiple Sclerosis (MS)Myasthenia Gravis (MG)Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)+1 more
Daishi Tian36 enrolled1 locationNCT07337785